Thermo Fisher, Northeastern University partner to advance analytical capabilities
The partnership will develop advanced analytical solutions and deliver training to address the current requirements of the biopharmaceutical…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Nov 20
The partnership will develop advanced analytical solutions and deliver training to address the current requirements of the biopharmaceutical…
PharmaceuticalsConsulting, Training and Other Pharmaceutical Services
04 Nov 20
Vupanorsen is an investigational antisense therapy, discovered by Ionis Pharmaceuticals and co-developed by Ionis and its subsidiary Akcea…
03 Nov 20
Tecentriq plus Avastin is the first and only approved cancer regimen for unresectable hepatocellular carcinoma (HCC) in Europe
02 Nov 20
Adakveo is claimed to be the first targeted sickle cell disease therapy for prevention of recurrent vaso-occlusive crises…
02 Nov 20
Collaboration with GeneQuantum follows Samsung Biologics' recent partnership with China-based biotech company APRINOIA Therapeutics
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Oct 20
GSK said that Zejula is the first monotherapy for patients with platinum-responsive advanced ovarian cancer in the European…
29 Oct 20
Molecular Partners will receive an upfront payment of $65.97m, and an additional payment of $164.93m after the option…
28 Oct 20
CStone’s licencing agreement enables EQRx to develop and commercialise the two late-stage immuno-oncology drugs outside of Greater China
28 Oct 20
Pfizer’s regulatory filing for abrocitinib is based on clinical trial data showing improvement in symptoms, along with a…
27 Oct 20
Bayer will add AskBio’s advanced adeno-associated virus (AAV)-based gene therapy platform to its cell and gene therapy (CGT)…